Researchers Submit Patent Application, "Stearoyl-Coa Desaturase 5 (Scd5) Irna Agent Compositions And Methods Of Use Thereof", for Approval (USPTO 20240200077).

This document is a patent application for a new method of treating Parkinson's disease. The application describes the use of a double stranded ribonucleic acid (dsRNA) agent that targets the Stearoyl-CoA Desaturase 5 (Scd5) gene. The dsRNA agent consists of a sense strand and an antisense strand, with the antisense strand being complementary to the target gene. The patent application provides detailed information on the specific nucleotide sequences, modifications, and conjugations that can be used in the dsRNA agent. The application also mentions the potential use of the dsRNA agent in treating Parkinson's disease and other movement disorders. [Extracted from the article]